Paper Details

  1. Home
  2. Paper Details

Prednisone compared to methylprednisolone in the polymyalgia rheumatica treatment.

Author: AdamiSilvano, FracassiElena, GattiDavide, IdolazziLuca, RossiniMaurizio, TropliniSonila, ViapianaOmbretta

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Glucocorticoids (GLs) are the primary treatment for polymyalgia rheumatica (PMR), but some patients require high doses or respond better to specific types of GLs. This study compared the effectiveness of prednisone (PN) and methylprednisolone (MPONE) in PMR patients, finding that MPONE may offer faster symptom relief and a shorter time to achieve remission.
Paper Details　
Original Abstract of the Article :
Glucocorticoids (GLs) are the sole therapeutic approach in polymyalgia rheumatica (PMR). An undefined proportion of patients respond only to very high doses of GLs and some seem to respond better to methylprednisolone (MPONE) than to prednisone (PN) or vice versa. Fifty-two PMR patients were randomi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/s00296-014-3105-0

データ提供：米国国立医学図書館（NLM）

Prednisone vs. Methylprednisolone in Polymyalgia Rheumatica: A Comparative Trial

Polymyalgia rheumatica (PMR), a condition causing muscle pain and stiffness, is often treated with glucocorticoids. This study compares the effectiveness of prednisone and methylprednisolone, two commonly used glucocorticoids, in managing PMR. The researchers conducted a randomized controlled trial to evaluate the efficacy and time to remission of these drugs in patients with PMR. This study aimed to determine whether one glucocorticoid was more effective or led to faster remission in patients with PMR.

Methylprednisolone: A Potential Advantage in Time to Remission

The study found that both prednisone and methylprednisolone were effective in achieving clinical and biochemical remission in PMR patients. However, methylprednisolone demonstrated a significantly shorter time to achieve full remission compared to prednisone. This suggests that methylprednisolone may be a more efficient option for achieving rapid symptom relief in PMR patients. This study provides valuable insights into the comparative effectiveness of different glucocorticoids in managing PMR and underscores the importance of selecting the most appropriate treatment for individual patients.

Tailoring Treatment Approaches for Polymyalgia Rheumatica

The study's findings highlight the importance of tailoring treatment approaches for PMR based on individual patient needs and preferences. While both prednisone and methylprednisolone are effective, the faster time to remission observed with methylprednisolone may be advantageous for patients seeking rapid symptom relief. This research underscores the need for careful consideration of the individual characteristics and goals of patients when choosing a glucocorticoid for PMR management.

Dr.Camel's Conclusion

Just as the desert offers multiple pathways to navigate, the treatment of polymyalgia rheumatica involves a choice between different glucocorticoids. This study sheds light on the comparative effectiveness of prednisone and methylprednisolone, suggesting that methylprednisolone may offer a faster route to symptom relief. By understanding the nuances of these medications, we can select the most appropriate treatment option for each patient, ensuring a smoother and more comfortable journey towards remission.

Date :
  1. Date Completed 2016-02-23
  2. Date Revised 2021-10-21
Further Info :

Pubmed ID

25149179

DOI: Digital Object Identifier

10.1007/s00296-014-3105-0

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.